News Channels

10 Jul 2018 Recursion Receives FDA Clearance of Investigational New Drug Application to Initiate First Clinical Trial of REC-994 in Cerebral Cavernous Malformation
10 Jul 2018 NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology
10 Jul 2018 Achillion Initiates Phase I First-in-Human Study of ACH-5548, a Third Oral Small Molecule Inhibitor of Complement Factor D
10 Jul 2018 miRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
10 Jul 2018 Filament BioSolutions Announces Collaboration with Ajinomoto for the Development of FB-2710 for Radiation-Induced Oral Mucositis
10 Jul 2018 Seattle Genetics and Astellas Announce Progress in Enfortumab Vedotin Urothelial Cancer Clinical Development Program
10 Jul 2018 Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE' Study in Adults with Transfusion-Dependent Beta-Thalassemia
10 Jul 2018 Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection
10 Jul 2018 Spero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994
10 Jul 2018 Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
10 Jul 2018 MabVax Therapeutics and Boehringer Ingelheim Sign Asset Purchase and License Agreement and Related Agreements for an Antibody Development Program Targeting Multiple Solid Tumor Cancers
10 Jul 2018 Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial
10 Jul 2018 Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma
10 Jul 2018 BELLUS Health Initiates Phase 1 Clinical Study for its Chronic Cough Drug Candidate, BLU-5937
10 Jul 2018 JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Rituximab Biosimilar
10 Jul 2018 XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation
10 Jul 2018 Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of PIXUVRI® (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
06 Jul 2018 Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki
06 Jul 2018 Orion has started a Phase III trial to develop a drug for ALS - The patient recruitment has begun
06 Jul 2018 JHL Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up